Get in Touch

Optimising the PRMA potential of an orphan oncology asset in EU4 + UK and Japan

  • Price Optimisation, Access Strategy
I really appreciated P4A’s thoughtful and comprehensive approach to this complicated problem! And for shining a light on the opportunities in Europe and Japan.
Market Access Lead

Client Challenge

Identifying strategic recommendations to optimise the PRMA opportunity for an orphan oncology asset

A mid-sized pharma company are planning for the launch of a novel targeted therapy in multiple solid tumour indications.

In a complex and rapidly evolving competitive landscape, our client needed to understand how their evidence package would be perceived by payers and the impact of the competitive landscape.

P4A Solution

P4A conducted interviews with payers and KOLs from the EU4 markets, plus UK and Japan to:

  • Develop a clear picture of the likely HTA outcomes and price potential across markets
  • Highlight key risks to the access and price potential of the client’s product

Japan was a critical scope market as the client team’s expertise is primarily on European markets. P4A supported the client in understanding the PRMA process in Japan, including the price premium system in relation to their asset

The Successful Outcome​

  • Recommendations on how to mitigate the impact of a recent competitor launch; considering HTA outcomes, price potential and likely physician uptake
  • An in-depth analysis of the price potential for the client’s product across markets, considering multiple possible scenarios
  • Recommendations for life cycle management, with a specific  emphasis on the importance of this in terms of price erosion

Need more details?

Do you want to learn more about the successful outcome for this case study? Are you interested in P4A Services or just want to say Hi?

get in touch

Explore other case studies

Understand evidence requirements beyond clinical trial data for launching an orphan drug in Türkiye & the GCC

  • Access Strategy

P4A partnered with Company A to assist in developing the launch strategy for Product A in South Korea

  • Access Strategy
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact

P4A Services

For all access and Rare Disease related overview enquiries